22nd century group provides business update from ceo detailing company progress over past year and future initiatives

Buffalo, n.y., june 25, 2021 (globe newswire) -- 22nd century group, inc. (nyse american: xxii), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today released an update letter to its shareholders from ceo james a. mish.
XXII Ratings Summary
XXII Quant Ranking